These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32210745)

  • 1. The Effect of Estrogen Replacement Therapy on Alzheimer's Disease and Parkinson's Disease in Postmenopausal Women: A Meta-Analysis.
    Song YJ; Li SR; Li XW; Chen X; Wei ZX; Liu QS; Cheng Y
    Front Neurosci; 2020; 14():157. PubMed ID: 32210745
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.
    Wu M; Li M; Yuan J; Liang S; Chen Z; Ye M; Ryan PM; Clark C; Tan SC; Rahmani J; Varkaneh HK; Bhagavathula AS
    Pharmacol Res; 2020 May; 155():104693. PubMed ID: 32057896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
    Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
    Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis.
    Feldman AL; Johansson AL; Lambert PC; Sieurin J; Yang F; Pedersen NL; Wirdefeldt K
    Neuroepidemiology; 2014; 42(2):69-80. PubMed ID: 24296900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic reviews on neurodevelopmental and neurodegenerative disorders linked to pesticide exposure: Methodological features and impact on risk assessment.
    Hernández AF; González-Alzaga B; López-Flores I; Lacasaña M
    Environ Int; 2016; 92-93():657-79. PubMed ID: 26896854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.
    Gunnarsson LG; Bodin L
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691095
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and Parkinson's disease risk in women: a meta-analysis of 14 observational studies.
    Wang P; Li J; Qiu S; Wen H; Du J
    Neuropsychiatr Dis Treat; 2015; 11():59-66. PubMed ID: 25657580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.
    Xu Y; Lin J; Wang S; Xiong J; Zhu Q
    Kaohsiung J Med Sci; 2014 Jul; 30(7):350-61. PubMed ID: 24924841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between
    Chen J; Huang W; Cheng CH; Zhou L; Jiang GB; Hu YY
    Front Neurol; 2019; 10():290. PubMed ID: 30984100
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy for cognitive function in postmenopausal women.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003122. PubMed ID: 12137675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
    Greene RA
    Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
    Henderson VW; Paganini-Hill A; Emanuel CK; Dunn ME; Buckwalter JG
    Arch Neurol; 1994 Sep; 51(9):896-900. PubMed ID: 8080389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson's disease susceptibility.
    Weikang C; Jie L; Likang L; Weiwen Q; Liping L
    Open Med (Wars); 2016; 11(1):578-583. PubMed ID: 28352849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term estrogen replacement therapy on growth hormone response to pyridostigmine in healthy postmenopausal women.
    van Amelsvoort T; Murphy DG; Robertson D; Daly E; Whitehead M; Abel K
    Psychoneuroendocrinology; 2003 Jan; 28(1):101-12. PubMed ID: 12445839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between Parkinson's disease and melanoma: a systematic review and meta-analysis.
    Huang P; Yang XD; Chen SD; Xiao Q
    Transl Neurodegener; 2015; 4():21. PubMed ID: 26535116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-analysis on observational studies.
    Bayani M; Riahi SM; Bazrafshan N; Ray Gamble H; Rostami A
    Acta Trop; 2019 Aug; 196():165-171. PubMed ID: 31102579
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.